Pyridine and Pyridine Derivatives - Global Strategic Business Report

Global Pyridine and Pyridine Derivatives Market to Reach $1.1 Billion by 2030

The global market for Pyridine and Pyridine Derivatives estimated at US$683.7 Million in the year 2022, is projected to reach a revised size of US$1.1 Billion by 2030, growing at a CAGR of 6% over the analysis period 2022-2030. Pyridine, one of the segments analyzed in the report, is projected to record 6.9% CAGR and reach US$379.7 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Beta Picoline segment is readjusted to a revised 5.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $184.3 Million, While China is Forecast to Grow at 9.8% CAGR

The Pyridine and Pyridine Derivatives market in the U.S. is estimated at US$184.3 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$251.5 Million by the year 2030 trailing a CAGR of 9.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 4.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Select Competitors (Total 41 Featured) -

• Hubei Sanonda Co., Ltd.
• Koei Chemical Industry Co., Ltd.
• Shangdong Luba Chemical Co. Ltd.

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year